NASDAQ · ACONW
Healthcare · Medical - Healthcare Information Services
$0.03
Up+$0.01 (+23.83%)
Updated Sep 19, 2026, 1:20 PM
SID Score
3.5/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
ACONW does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning ACONW.
ACONW research
Company profile and research snapshot.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
GlobeNewswire Inc. · Jun 8, 2023
Nociscan cost-effectiveness abstract highlights dominance over provocative discography and can save the US healthcare system $283M to $441M annually.
GlobeNewswire Inc. · May 30, 2023
The London Clinic is the UK’s most renowned independent, private hospital, established 1932.
GlobeNewswire Inc. · May 23, 2023
Development of This Program Supports Aclarion’s Commitment to Lead With Strong Clinical Evidence and Engage the Payer Community Through Key Opinion Leader Advocacy
GlobeNewswire Inc. · May 19, 2023
Up to $2M Unsecured, Non-Convertible Bridge Debt With No Required Amortization Payments
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning ACONW.
No results
No recent SID articles mention ACONW.
